echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Weikang Pharmaceutical Obtains Supplementary Application Approval Notice for Qiancao Capsules and Gansu Capsules

    Weikang Pharmaceutical Obtains Supplementary Application Approval Notice for Qiancao Capsules and Gansu Capsules

    • Last Update: 2021-04-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 2, Weikang Pharmaceutical issued an announcement stating that it had recently received the approval of the National Medical Products Administration for the issuance of supplementary application approval notices for Qiancao Capsules and Gansu Capsules.


    The functions of Desmodium Lysimachia Capsules are: clearing damp-heat, dredging leaching and reducing swelling.


    Gansu Capsules functions and indications: lowering enzymes, protecting liver, relieving jaundice, and strengthening spleen.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.